Anzeige
Mehr »
Login
Dienstag, 07.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
+56,25% in 5 Tagen: Genialer Schachzug - diese Übernahme verändert alles
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
42 Leser
Artikel bewerten:
(0)

Scheduled Conference Presentations, Donations, and Stock Price Movements - Research Report on Community Health Systems, Bard, WellCare, PAREXEL, and Align Technology

NEW YORK, December 25, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting Community Health Systems, Inc. (NYSE: CYH), CR Bard Inc. (NYSE: BCR), WellCare Health Plans, Inc. (NYSE: WCG), PAREXEL International Corporation (NASDAQ: PRXL), and Align Technology Inc. (NASDAQ: ALGN). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Community Health Systems, Inc. Research Report

On December 20, 2013, Community Health Systems, Inc.'s (Community Health Systems) stock rose 3.12%, ending the day's trading at $38.29. Over the previous three trading sessions, shares of Community Health Systems increased 0.98%, compared to the Dow Jones Industrial Average Index which increased 2.18% during the same period. The Full Research Report on Community Health Systems, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/7587_CYH

--

CR Bard Inc. Research Report

On December 20, 2013, CR Bard Inc. (Bard) announced that the Company will make a presentation at the J.P. Morgan Healthcare Conference in San Francisco, California, on January 14, 2014. According to the Company, its Chairman and CEO, Timothy M. Ring, will discuss the Company in a presentation scheduled to begin at 2:30 p.m. PST. The Full Research Report on CR Bard Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/141e_BCR

--

WellCare Health Plans, Inc. Research Report

On December 20, 2013, WellCare Health Plans, Inc. (WellCare) reported that the Company recently donated $3,000 to Children's Safety Village of Central Florida, Inc. (CSV) through its Staywell Health Plan, to help children learn to recognize safety hazards, and acquire the safety skills that can prevent accidents and injuries. The Company informed that the donation will be used for three, free community events designed to teach water and transportation safety, prevent drowning and heatstroke, and provide strategies to combat cyberbullying. "Childhood injuries are a growing public health problem, but there are proven ways to reduce both the likelihood and severity of these injuries through education and prevention," said Juanita Black, Executive Director at CSV. "WellCare's support and generous donation are vital to meeting the growing need for safety education and injury prevention in our community." The Full Research Report on WellCare Health Plans, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/be48_WCG

--

PAREXEL International Corporation Research Report

On December 20, 2013, PAREXEL International Corporation's (PAREXEL) stock gained 3.94%, ending the day's trading session at $43.79. Over the previous three trading sessions, stock of PAREXEL increased 5.88%, compared to the Nasdaq Composite Index which increased 2.01% during the same period. The Full Research Report on PAREXEL International Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/067b_PRXL

--

Align Technology Inc. Research Report

On December 20, 2013, Align Technology Inc.'s (Align Technology) stock gained 0.99%, ending the day's trading session at $57.03. Over the previous three trading sessions, shares of Align Technology increased 1.84%, compared to the Nasdaq Composite Index which increased 2.01% during the same period. The Full Research Report on Align Technology Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/69b3_ALGN

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts' Corner

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.